m7(3'OMeG)(5')ppp(5')(2'OMeA)pG |
Catalog No.GN20152
One-Click Copy Product Info
|
m7(3'OMeG)(5')ppp(5')(2'OMeA)pG is a co-transcriptional capping reagent that can produce Cap 1 structure with a capping efficiency of up to 98%.
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
_1-3.$$$39978408@51.jpg');)
_1-9.$$$38538795@65.jpg');)
_1-9.$$$39112701@51.jpg');)
_1-7.$$$37316672@70.jpg');)
_366-372.$$$36198801@70.jpg');)
.$$$38565142@65.jpg');)
_1867-1883.$$$33248023@67.jpg');)
_eads6055.$$$39977546@45.jpg');)
_eadm9805.$$$40080571@45.jpg');)
_eadj3020.$$$39666821@45.jpg');)
_1-20.$$$39757301@28.jpg');)
_1-24.$$$38898113@28.jpg');)
_273-287.$$$36806353@46.jpg');)
_1-16.$$$37156877@44.jpg');)
_1-19.$$$37460805@44.jpg');)
_1291-1307.$$$34518654@46.jpg');)
m7(3'OMeG)(5')ppp(5')(2'OMeA)pG is a co-transcriptional capping reagent that can produce Cap 1 structure with a capping efficiency of up to 98%. m7(3'OMeG)(5')ppp(5')(2'OMeA)pG needs to be used with a specific 5' AG 3' start sequence.
Compared with Cap 0 structure (ARCA and mCap capping), mRNA with Cap 1 structure is more suitable for mammalian systems and has higher transcription and translation efficiency. It is often used in protein production, RNA therapy and vaccine research.
| purity | >95.00% | Extinction Coefficient | 30,539 Lmol-1cm-1 at 255 nm |
| Formula | C33H45N15O24P4 (free acid) | M.Wt | 1159.6 |
| Salt Form | Na+ | Concentration | 100 mM |
| Buffer | H2O | Storage | -20°C or below |
| Synonyms | 3'OMe-m7GpppAmpG | Backbone | 5'-5'-Triphosphate |
| Base Analog | Adenosine, Guanosine | Sugar Type | |
| Nucleotide Category | Cap analogs | ||
| Applications | CRISPR, In vitro Transcription, Recombinases, TALENS, Transposases, Vaccine Development, Zinc Finger Nucleases | ||
Average Rating: 5 (Based on Reviews and 4 reference(s) in Google Scholar.)